Top Small Cap Gainers: LX, UXIN, LCTX
9:51 pm Tuesday, June 01st, 2021
LexinFintech Holdings Ltd (NASDAQ:LX): jumped 28% to $11.70 as Investors are responding positively to the company’s unaudited financial results for the quarter ended March 31, 2021. — The total operating revenue reached RMB2.9 billion. And credit-oriented services income reached RMB1.8 billion, representing an increase of 8.9% from the first quarter of 2020. The platform-based services income reached RMB636 million, representing an increase of 122% from the first quarter of 2020.
Uxin Limited (NASDAQ:UXIN): stock gained 24.25% to $4.59 on short squeeze Uxin Limited, an investment holding company, operates a used car e-commerce platform in China. It provides selection of used cars, evaluation of car condition, various car-related value-added products and services, and supporting services to online used car transactions under the Uxin Used Car brand; and operates Uxin Auction, an application that helps business buyers to source vehicles through online auctions. The company also facilitates used car transaction services, and financing solutions offered by third-party financing partners to buyers for their used car purchases through websites, xin.com and youxinpai.com. Uxin Limited was founded in 2011 and is headquartered in Beijing, China.
Lineage Cell Therapeutics, Inc (NASDAQ: LCTX): moved up 21.50% to $2.88. The company announced today that restoration of retinal tissue was observed in two additional patients enrolled in the Company’s Phase 1/2a study of its lead product candidate, OpRegen. OpRegen is an allogeneic retinal pigment epithelium (RPE) cell transplant therapy in development for the treatment of age-related macular degeneration (AMD) with geographic atrophy (GA), or dry (atrophic) AMD.
